⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11959803 | 0.71 | — | — | |
| SCHEMBL776479 | 0.67 | — | — | |
| SCHEMBL10339280 | 0.67 | — | — | |
| SCHEMBL7030385 | 0.67 | — | — | |
| SCHEMBL7030384 | 0.67 | — | — | |
| SCHEMBL776480 | 0.67 | — | — | |
| SCHEMBL9609156 | 0.67 | — | — | |
| SCHEMBL16625504 | 0.65 | — | — | |
| SCHEMBL10951507 | 0.61 | — | — | |
| SCHEMBL29861937 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116270266-A | Use of zinc compounds in combination with hydrogen peroxide in oral malodour reduction products | 杭州纳美智康科技有限公司 | 2023-06-23 | — | — | CN | disclosed |